Vaccine drives revamped during J&J limbo status

Communities are having to readjust how they plan vaccination campaigns after the federal government called for a halt in the Johnson & Johnson doses, the only single-shot vaccine approved for COVID-19.


National News

April 16, 2021 - 2:28 PM

Communities across the U.S. are suddenly revamping their vaccination campaigns to adjust to an indefinite halt in Johnson & Johnson’s doses, which has required officials to reschedule tens of thousands of appointments as they seek to reassure people that COVID-19 vaccines are safe.

Health professionals are split on whether the delay should continue. On the one hand, the blood-clotting syndrome that led to the pause in J&J vaccinations is serious and can be deadly. Conversely, with J&J doses out of circulation, that means fewer people are getting immunized even as fast-spreading COVID variants are tightening their grip, and concern about the J&J shots risks expanding vaccine hesitancy.

Hospitals, pharmacies and health departments are clambering to vaccinate people who were scheduled to receive J&J shots this week. Some key initiatives that relied on the one-shot vaccine like those reaching homebound seniors or pop-up clinics are being halted altogether. Officials are trying to answer questions and combat safety worries from an already skeptical public.

May 17, 2022
October 22, 2021
August 17, 2021
February 25, 2021